A Study to Evaluate the Effect of ACP-196 on the Heart Rate-corrected QT Interval in Healthy Adult Participants

Trial Identifier:	ACE-HV-005
Sponsor:	Acerta Pharma BV
NCTID::	NCT04867980
Start Date:	April 2016
Primary Completion Date:	May 2016
Study Completion Date:	May 2016
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, Arizona	Tempe, Arizona, US, 85283

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.